Direkt zum Inhalt
Merck

S6322

Sigma Adjuvant System®

oil

Synonym(e):

Adjuvanssystem, Sigma-Adjuvans

Slide 1 of 2
Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

S6322-1VL

€ 221,00

€ 221,00

Warenkorb auf Verfügbarkeit prüfen
​
Großbestellung anfragen

Über diesen Artikel

NACRES:
NA.46
UNSPSC Code:
12352203

Wichtige Dokumente

Gesamtdokumentation anzeigen

Fortfahren mit

Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten

form

oil

Quality Level

300

storage temp.

2-8°C

Verwandte Kategorien

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 4

Dieser Artikel
C5650SML0154F5506
Sigma Adjuvant System® oil

Sigma-Aldrich

S6322

Sigma Adjuvant System®

Cod liver oil fatty acid methyl esters

Sigma-Aldrich

C5650

Cod liver oil fatty acid methyl esters

SPV-106 ≥98% (HPLC)

Sigma-Aldrich

SML0154

SPV-106

Freund’s Adjuvant, Incomplete liquid

Sigma-Aldrich

F5506

Freund′s Adjuvant, Incomplete

form

oil

form

oil

form

oil

form

liquid

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

Quality Level

300

Quality Level

200

Quality Level

100

Quality Level

300

Application

Adjuvantizitätsassay: EIA-Titer für Testmäuse ist mindestens 2x größer als der von Kontrollmäusen.

Biochem/physiol Actions

Das Sigma Adjuvans-System ist eine stabile Öl-in-Wasser-Emulsion, die als Alternative zu den klassischen Wasser-in-Öl-Emulsionen nach Freund verwendet werden kann. Es wird aus bakteriellen und mykobakteriellen Zellwandbestandteilen gewonnen, die einen potenten Stimulus für das Immunsystem bereitstellen.

Physical form

Jedes Fläschchen enthält 0,5 mg Monophosphoryl-Lipid A (detoxifiziertes Endotoxin) aus Salmonella minnesota und 0,5 mg synthetisches Trehalosedicorynomycolat in 2 % Öl(Squalen)-Tween® 80-Wasser.

Legal Information

Sigma Adjuvant System is a registered trademark of Merck KGaA, Darmstadt, Germany
TWEEN is a registered trademark of Croda International PLC

Disclaimer

Sofern in unserem Katalog oder anderen Begleitdokumenten unserer Produkte nicht anders angegeben, sind unsere Produkte nur für Forschungszwecke vorgesehen und nicht für andere Zwecke zu verwenden, einschließlich, jedoch nicht beschränkt auf unautorisierte kommerzielle Verwendung, zur In-vitro-Diagnostik, für Ex-vivo- oder In-vivo-Therapiezwecke oder jegliche Art der Einnahme oder Anwendung bei Menschen oder Tieren.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

08168

Timestrip Plus™ 8 °C

pictograms

Health hazard
GHS08

signalword

Danger

hcodes

H304

Hazard Classifications

Asp. Tox. 1

Lagerklasse

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
0000520052
0000520052
0000407553
0000407553
0000329924

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Déirdre B Ní Eidhin et al.
FEMS immunology and medical microbiology, 52(2), 207-218 (2007-12-21)
Clostridium difficile is the leading cause of infectious antibiotic-associated diarrhoea, particularly among the elderly. Its surface-layer protein (SLP) was tested as a vaccine component in a series of immunization and challenge experiments with Golden Syrian hamsters, combined with different systemic
Avi-Hai Hovav et al.
Infection and immunity, 73(1), 250-257 (2004-12-25)
In this study, we examined the immunogenicity and protective efficacy of six immunodominant Mycobacterium tuberculosis recombinant antigens (85B, 38kDa, ESAT-6, CFP21, Mtb8.4, and 16kDa) in a multivalent vaccine preparation (6Ag). Gamma interferon (IFN-gamma) and monophosphoryl lipid A-trehalose dicorynomycolate (Ribi) adjuvant
Nadja Thönes et al.
Journal of virology, 82(11), 5472-5485 (2008-04-04)
Capsomeres are considered to be an alternative to viruslike particle (VLP)-based vaccines as they can be produced in prokaryotic expression systems. So far, no detailed side-by-side comparison of VLPs and capsomeres has been performed. In the present study, we immunized
Christina Schellenbacher et al.
Journal of virology, 83(19), 10085-10095 (2009-07-31)
The amino (N) terminus of the human papillomavirus (HPV) minor capsid protein L2 can induce low-titer, cross-neutralizing antibodies. The aim of this study was to improve immunogenicity of L2 peptides by surface display on highly ordered, self-assembled virus-like particles (VLP)
Development of monoclonal antibodies specific for Ricinus agglutinins
Brandon DL and Hernlem BJ
Food and agricultural immunology, 20(1), 11-22 (2009)
Alle zugehörigen Dokumente anzeigen

Artikel

An Introduction to Antibodies: Antigens, Epitopes and Antibodies

Antibodies combine with specific antigens to generate an exclusive antibody-antigen complex. Learn about the nature of this bond and its use as a molecular tag for research.

Verwandter Inhalt

Antibody Support Reagents

Access high-quality reagents for antibody workflows, including adjuvants, blocking reagents, conjugation kits, and more.

Product Information Sheet-S6322

Questions

1–8 of 8 Questions  

  1. Is the adjuvant ready to use? I don't see any mention in the datasheet on how to prepare the Antigen:adjuvant mixture. Can you help with that? Thank you.

    1 answer

    1. This product requires dilution with saline prior to use. This dilution can be done with or without the addition of the antigen. See below for a brief protocol.

      Prior to antigen addition, warm contents of vial to 40-45 °C. Add 2.0 mL of sterile saline containing the desired amount of antigen.
      The final emulsion will contain a concentration of 2% oil.
      1. Inject antigen-saline solution (2 mL) directly into the vial through the rubber stopper using a syringe fitted with a 20 or 21-gauge needle (leave the cap seal in place).
      2. Vortex the vial vigorously for 2 to 3 minutes to form emulsion. Invert the vial and vortex for 1 minute to ensure reconstitution of any product adhering to the stopper.
      3. If the entire contents of the vial will not be used initially, reconstitute with 1 ml saline without antigen. This emulsion can be stored at 2-8 °C for up to 60 days. Do Not freeze.
      To use, mix aliquots 1:1 with antigen in saline.
      4. Prior to inoculation, warm the vial to 37 °C and vortex briefly.

      For full details on injection protocols and boosting, please navigate to the link https://www.sigmaaldrich.com/techservice, click on "Product Technical Inquiries" under the Products Section with all the required information so that a member of the Technical Service team can reach out to assist further. Thank you.

      Helpful?

  2. When using the Sigma Adjuvant System® reagent, Product No. S6322, how do the components MPL and TDM work as an adjuvant?

    1 answer

    1. MPL (monophosphoryl lipid A) will bind to CD14 on the cell surface similar to LPS.  TDM (trehalose dicorynomycolate) is an analog of one of the components of the tubercle bacillus. Both of these components act like a superantigen and activate the immune system nonspecifically.  This allows for a greater response to the immunogen delivered in this adjuvant.

      Helpful?

  3. What is the Department of Transportation shipping information for this product?

    1 answer

    1. Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.

      Helpful?

  4. Is the Sigma Adjuvant System®, Product No S6322, the same as the RIBI adjuvant?

    1 answer

    1. Yes, the Sigma Adjuvant System®, Product No S6322, is also called RIBI adjuvant.

      Helpful?

  5. Has Sigma Adjuvant System®, Product S6322, been used to induce EAE (Experimental autoimmune encephalomyelitis)?

    1 answer

    1. Sigma Adjuvant System®, Product S6322 is a replacement for MPT+TDM adjuvant (Ribi, Product M6536) that was discontinued by the supplier Corixa.  Although we have not tested Product S6322 for induction of Experimental autoimmune encephalomyelitis (EAE), the following reference cites the use of MBP in Ribi adjuvant for induction of acute EAE.The Journal of ImmunologyOctober 15, 2005, 175(8): 5077-5086

      Helpful?

  6. When using the Sigma Adjuvant System®, Product No. S6322, how is the antigenic response boosted?

    1 answer

    1. With the Sigma Adjuvant System® (Product No. S6322) with mice, rabbits, rats and guinea pigs; boost on day 21 or 28, bleed 10 - 14 days after booster injection. Boost every 3 - 4 weeks thereafter. For goats; boost every four weeks. Use the same protocol for each injection.  For more information please see the Product Information Sheet for Product No. S6322.

      Helpful?

  7. Can you reconstitute and store the Sigma Adjuvant System® reagent (Product No. S6322) if not using the entire vial right away?

    1 answer

    1. If the entire contents of the vial will not be used initially, reconstitute with 1 ml saline without antigen.  This emulsion can then be stored at 2-8 °C for up to 60 days.  Do Not Freeze. To use, mix aliquots 1:1 with antigen in saline. Prior to inoculation, warm the vial to 37 °C and vortex briefly.  This and other information can be found on the Sigma Adjuvant System® reagent (Product No. S6322) Product Information Sheet.

      Helpful?

  8. What is used to solubilize Product No. S6322, Sigma Adjuvant System® reagent?

    1 answer

    1. The Sigma Adjuvant System® reagent (Product No. S6322) can be solubilized in a sterile saline solution containing the desired amount of antigen to a final volume of 2 ml.  For more details, please see the S6322 Product Information Sheet.

      Helpful?

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung